^
    over3years
    [VIRTUAL] Molecular profiling of BRCA1/2 genes by NGS in tumoral samples from ovarian cancer patients (ECP 2021)
    These results indicate that the analysis in tumoral tissue has adequate sensitivity for the detection of germline mutations in the BRCA1/2 genes if the quality of the tissue DNA is sufficient. Furthermore, the tumoral biopsy study allows us to identify somatic al- terations in these genes.
    Clinical • BRCA Biomarker • Next-generation sequencing
    |
    BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset) • BRCA (Breast cancer early onset)
    |
    BRCA2 mutation • BRCA1 mutation
    |
    BRCAplus® • Oncomine™ BRCA Research Assay